Clinical Trial Update: An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer [Phase 1]

View source ↗

Summary

An investigational PET/CT imaging tracer, 124I-hJAA-F11, being evaluated for diagnosing lung cancer in a Phase 1 trial has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• 124I-hJAA-F11 (Iodine-124 labeled hJAA-F11)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Extensive-stage Small-cell Lung Cancer, Limited-stage Small-cell Lung Cancer | Phase 1 | Status: WITHDRAWN